PerkinElmer Acquires Improvision Ltd.

04-Apr-2007

PerkinElmer, Inc. announced that it has acquired Improvision Ltd. in a cash transaction. Based in Coventry, United Kingdom, Improvision is a provider of cellular imaging software and integrated hardware solutions used in life sciences research. The company had revenue of approximately GBP 6 million (BPS) in 2006.

"This acquisition strengthens our leading capability in the fast-growing field of advanced cellular sciences," said Gregory L. Summe, chairman and chief executive officer, PerkinElmer, Inc. "PerkinElmer now provides pharmaceutical and academic researchers with a single source for imaging and analysis solutions that will help increase their understanding of disease mechanisms at the cellular level, potentially speeding the development of new therapies for conditions such as Alzheimer's, Parkinson's, diabetes and cancer."

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy